» Articles » PMID: 438117

Relationship Between Lysostaphin Endopeptidase Production and Cell Wall Composition in Staphylococcus Staphylolyticus

Overview
Journal J Bacteriol
Specialty Microbiology
Date 1979 Mar 1
PMID 438117
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Mutants of Staphylococcus staphylolyticus incapable of producing an extracellular staphylolytic glycylglycine endopeptidase were isolated and found to have cells in the population susceptible to lysis by this enzyme, as did the wild-type organism under conditions in which the endopeptidase was not produced. These results suggest that cultures of this organism normally contain a heterogeneous population of cells with regard to cell wall composition and susceptibility to the enzyme. Production of the endopeptidase appears to act as a selective pressure which removes the susceptible cells in the population as the enzyme appears in the medium. A comparison of the peptidoglycan of the wild-type organism grown under conditions in which the endopeptidase was produced with that of this organism grown under nonproducing conditions and with those of endopeptidase-less mutants showed that in the presence of the endopeptidase the cell population had peptidoglycan with shorter peptide cross bridges and a greater percentage of serine in these cross bridges than was found in cells grown in the absence of the enzyme. The inability of the endopeptidase to hydrolyze glycylserine and serylglycine peptide bonds suggests that at least part of the resistance this organism has to the endopeptidase is due to relative amounts of serine found in the peptide cross bridges of some cells in the population.

Citing Articles

Agents Targeting the Bacterial Cell Wall as Tools to Combat Gram-Positive Pathogens.

Zhydzetski A, Glowacka-Grzyb Z, Bukowski M, Zadlo T, Bonar E, Wladyka B Molecules. 2024; 29(17).

PMID: 39274911 PMC: 11396672. DOI: 10.3390/molecules29174065.


A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity.

Grishin A, Konstantinova S, Vasina I, Shestak N, Karyagina A, Lunin V Antibiotics (Basel). 2020; 9(12).

PMID: 33348544 PMC: 7766845. DOI: 10.3390/antibiotics9120917.


FmhA and FmhC of incorporate serine residues into peptidoglycan cross-bridges.

Willing S, Dyer E, Schneewind O, Missiakas D J Biol Chem. 2020; 295(39):13664-13676.

PMID: 32759309 PMC: 7521636. DOI: 10.1074/jbc.RA120.014371.


The length of lipoteichoic acid polymers controls cell size and envelope integrity.

Hesser A, Matano L, Vickery C, Wood B, Santiago A, Morris H J Bacteriol. 2020; .

PMID: 32482719 PMC: 8404710. DOI: 10.1128/JB.00149-20.


Intracellular morphological changes in Staphylococcus aureus induced by treatment with sodium hypochlorite.

Ujimine S, Tone S, Saito M, Yamada S Med Mol Morphol. 2017; 50(3):178-184.

PMID: 28516285 DOI: 10.1007/s00795-017-0159-6.


References
1.
SCHINDLER C, SCHUHARDT V . PURIFICATION AND PROPERTIES OF LYSOSTAPHIN--A LYTIC AGENT FOR STAPHYLOCOCCUS AUREUS. Biochim Biophys Acta. 1965; 97:242-50. DOI: 10.1016/0304-4165(65)90088-7. View

2.
Kloos W, Pattee P . A BIOCHEMICAL CHARACTERIZATION OF HISTIDINE-DEPENDENT MUTANTS OF STAPHYLOCOCCUS AUREUS. J Gen Microbiol. 1965; 39:185-94. DOI: 10.1099/00221287-39-2-185. View

3.
BROWDER H, Zygmunt W, Young J, Tavormina P . LYSOSTAPHIN: ENZYMATIC MODE OF ACTION. Biochem Biophys Res Commun. 1965; 19:383-9. DOI: 10.1016/0006-291x(65)90473-0. View

4.
Cropp C, Harrison E . THE IN VITRO EFFECT OF LYSOSTAPHIN ON CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS. Can J Microbiol. 1964; 10:823-8. DOI: 10.1139/m64-107. View

5.
SCHINDLER C, SCHUHARDT V . LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. Proc Natl Acad Sci U S A. 1964; 51:414-21. PMC: 300087. DOI: 10.1073/pnas.51.3.414. View